Pro- and anti-apoptotic roles for IGF-I in TNF-α-induced apoptosis: A MAP kinase mediated mechanism

Growth Factors

Volumn 26, Issue 5, 2008, Pages 239-253

  Saini, Amarjit ^a   Al Shanti, Nasser ^a   Faulkner, Steve H ^a   Stewart, Claire E ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; IGF I; MAP kinase; Myoblasts; TNF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT SOMATOMEDIN C; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; MOLECULAR MECHANICS; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS, SKELETAL; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RODENTIA;

EID: 52649129311     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802291634     Document Type: Article

References (44)

1. Acharyya, S., Ladner, KJ, Nelsen, LL, Damrauer, J., Reiser, PJ, Swoap, S. and Guttridge, DC (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest, 114:3, pp. 370-378.
2. Algeciras-Schimnich, A., Barnhart, BC and Peter, ME (2002) Apoptosis-independent functions of killer caspases. Curr Opin Cell Biol, 14:6, pp. 721-726.
3. Andersen, JL, Schjerling, P. and Saltin, B. (2000) Muscle, genes and athletic performance. Sci Am, 283:3, pp. 48-55.
4. Argiles, JM, Alvarez, B. and Lopez-Soriano, FJ (1997) The metabolic basis of cancer cachexia. Med Res Rev, 17:5, pp. 477-498.
5. Argiles, JM, Moore-Carrasco, R., Busquets, S. and Lopez-Soriano, FJ (2003) Catabolic mediators as targets for cancer cachexia. Drug Discovery Today, 8:18, pp. 838-844.
6. Coroneos, E., Wang, Y., Panuska, JR, Templeton, DJ and Kester, M. (1996) Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem J, 316, pp. 13-17.
7. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, PG, Coso, OA, Gutkind, S. and Spiegel, S. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381:6585, pp. 800-803.
8. Dirks, AJ and Leeuwenburgh, C. (2005) The role of apoptosis in age-related skeletal muscle atrophy. Sports Med, 35, pp. 473-483.
9. Dorrens, J. and Rennie, MJ (2003) Effects of ageing and human whole body and muscle protein turnover. Scand J Med Sci Sports, 13:1, pp. 26-33.
10. Florini, JR and Ewton, DZ (1995) IGFs, muscle growth, and myogenesis. Diabetes Metab Rev, 3, pp. 73-92.
11. Florini, JR, Magri, KA, Ewton, DZ, James, PL, Grindstaff, K. and Rotwein, PS (1991) "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem, 266:24, pp. 15917-15923.
12. Foulstone, EJ, Meadows, KA, Holly, JM and Stewart, CE (2001) Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J Cell Physiol, 189:2, pp. 207-215.
13. Foulstone, EJ, Huser, C., Crown, AL, Holly, JM and Stewart, CE (2004) Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: Roles of IGF-I and TNFalpha. Exp Cell Res, 294:1, pp. 223-235.
14. Glass, DJ (2003) Molecular mechanisms modulating muscle mass. Trends Mol Med, 9:8, pp. 344-350.
15. Hannun, YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science, 274:5294, pp. 1855-1859.
16. Harridge, SD (2003) Ageing and local growth factors in muscle. Scand J Med Sci Sports, 13:1, pp. 34-39.
17. Jarvis, WD, Kolesnick, RN, Fornari, FA, Traylor, RS, Gewirtz, DA and Grant, S. (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA, 91:1, pp. 73-77.
18. Jayadev, S., Liu, B., Bielawska, AE, Lee, JY, Nazaire, F., Pushkareva, M., Obeid, LM and Hannun, YA (1995) Role for ceramide in cell cycle arrest. J Biol Chem, 270:5, pp. 2047-2052.
19. Kawakami, A., Nakashima, T., Tsuboi, M., Urayama, S., Matsuoka, N., Ida, H., Kawabe, Y., Sakai, H., Migita, K., Aoyagi, T., Nakashima, M., Maeda, K. and Eguchi, K. (1998) Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochem Biophys Res Commun, 247:1, pp. 46-51.
20. Kooijman, R. (2006) Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev, 17:4, pp. 305-323.
21. Lang, CH, Frost, RA, Nairn, AC, MacLean, DA and Vary, TC (2002) TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol, 282:2, pp. E336-E347.
22. Lin, ADB (2002) The true face of JNK activation in apoptosis. Ageing Cell, 1:2, pp. 112-116.
23. Li, YP, Schwartz, RJ, Waddell, ID, Holloway, BR and Reid, MB (1998) Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J, 12:10, pp. 871-880.
24. Li, YP, Lecker, SH, Chen, Y., Waddell, ID, Goldberg, AL and Reid, MB (2003) TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J, 17:9, pp. 1048-1057.
25. Llovera, M., Carbo, N., Lopez-Soriano, J., Garcia-Martinez, C., Busquets, S., Alvarez, B., Agell, N., Costelli, P., Lopez-Soriano, FJ, Celada, A. and Argiles, JM (1998) Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett, 133:1, pp. 83-87.
26. McConkey, DJ and Orrenius, S. (1994) Signal transduction pathways to apoptosis. Trends Cell Biol, 4:10, pp. 370-375.
27. Mitch, WE and Price, SR (2001) Transcription factors and muscle cachexia: Is there a therapeutic target?. Lancet, 357:9258, pp. 734-735.
28. Niesler, CU, Urso, B., Prins, JB and Siddle, K. (2000) IGF-I inhibits apoptosis induced by serum withdrawal, but potentiates TNF-alpha-induced apoptosis, in 3T3-L1 preadipocytes. J Endocrinol, 167:1, pp. 165-174.
29. Raile, K., Hille, R., Laue, S., Schulz, A., Pfeifer, G., Horn, F. and Kiess, W. (2003) Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: Co-activation of pro- and anti-apoptotic pathways by IGF-I. Horm Metab Res, 35:11, pp. 786-793.
30. Raines, MA, Kolesnick, RN and Golde, DW (1993) Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem, 268:20, pp. 14572-14575.
31. Remacle-Bonnet, M., Garrouste, F., Baillat, G., Andre, F., Marvaldi, J. and Pommier, G. (2005) Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Am J Pathol, 167:3, pp. 761-773.
32. Saile, B., DiRocco, P., Dudas, J., El-Armouche, H., Sebb, H., Eisenbach, C., Neubauer, K. and Ramadori, G. (2004) IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest, 84:8, pp. 1037-1049.
33. Schneider, JW, Gu, W., Zhu, L., Mahdavi, V. and Nadal-Ginard, B. (1994) Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science, 264:5164, pp. 1467-1471.
34. Spiegelman, BM and Hotamisligil, GS (1993) Through thick and thin: Wasting, obesity, and TNF alpha. Cell, 73:4, pp. 625-627.
35. Stewart, CE and Rotwein, P. (1996) Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev, 76:4, pp. 1005-1026.
36. Stewart, CE, Newcomb, PV, Savage, PB, Dickens, M., Tavare, J. and Holly, JM (1999) Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis. Growth Horm IGF Res, 9:2, pp. 131-142.
37. Stewart, CE, Newcomb, PV and Holly, JM (2004) Multifaceted roles of TNF-alpha in myoblast destruction: A multitude of signal transduction pathways. J Cell Physiol, 198:2, pp. 237-247.
38. Szewczyk, NJ and Jacobson, LA (2005) Signal-transduction networks and the regulation of muscle protein degradation. Int J Biochem Cell Bio, 37:10, pp. 1997-2011.
39. Tisdale, MJ (1997) Cancer cachexia: Metabolic alterations and clinical manifestations. Nutrition, 13:1, pp. 1-7.
40. Tisdale, MJ (2002) Cachexia in cancer patients. Nat Rev Cancer, 2:11, pp. 862-871.
41. Verheij, M., Bose, R., Lin, XH, Yao, B., Jarvis, WD, Grant, S., Birrer, MJ, Szabo, E., Zon, LI, Kyriakis, JM, Haimovitz-Friedman, A., Fuks, Z. and Kolesnick, RN (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature, 380:6569, pp. 75-79.
42. Volpi, E., Nazemi, R. and Fujita, S. (2004) Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care, 7:4, pp. 405-410.
43. Xia, Z., Dickens, M., Raingeaud, J., Davis, RJ and Greenberg, ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270:5240, pp. 1326-1331.
44. Yaffe, D. and Saxel, O. (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature, 270:5639, pp. 725-727.